BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26907188)

  • 1. Atypical glandular cells and risk of cervical cancer.
    Burki TK
    Lancet Oncol; 2016 Mar; 17(3):e96. PubMed ID: 26907188
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
    Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
    BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of TruScreen in detecting ASCUS patients.
    Li W; Guo Y; Niu H; Jin S; Wang L
    Asian Pac J Trop Med; 2011 Aug; 4(8):669-71. PubMed ID: 21914550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the abnormal Pap smear.
    Homesley HD
    Am Fam Physician; 1977 Sep; 16(3):190-4. PubMed ID: 900003
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevalence, genotype distribution of human papillomavirus and cervical cytology in Wenzhou, China: a retrospective research of 7391 cases.
    Lin Q; Lin X; Zhuang X; Tang Y; Zhao Z
    Diagn Cytopathol; 2021 Feb; 49(2):211-218. PubMed ID: 32965784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of cervical smear abnormalities using the revised Bethesda system in a tertiary care hospital in Western Saudi Arabia.
    Altaf FJ; Mufti ST
    Saudi Med J; 2012 Jun; 33(6):634-9. PubMed ID: 22729118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ThinPrep liquid-based cervical cytology: a retrospective analysis of 50,340 cases].
    Ma AG; Li Y; He QZ; Ye JL; Lu HJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Feb; 38(2):127-8. PubMed ID: 19573361
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of high-grade cervical lesion in women with LSIL and HSIL cytology and prevalence of invasive cancer in women cytologically positive for malignancy.
    Boonlikit S
    Asian Pac J Cancer Prev; 2008; 9(4):715-8. PubMed ID: 19256765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The equivocal Pap test: its past, present, and future.
    Selvaggi SM
    Diagn Cytopathol; 2010 Jul; 38(7):471-2. PubMed ID: 19941377
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpreting epithelial cell abnormalities detected during cervical smear screening--a cytohistologic approach.
    Patel TS; Bhullar C; Bansal R; Patel SM
    Eur J Gynaecol Oncol; 2004; 25(6):725-8. PubMed ID: 15597851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uterine cervix smears: their strengths and weaknesses in 2008].
    Vacher-Lavenu MC
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S87-9. PubMed ID: 18984314
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical glandular cells in Papanicolaou test: Which is more important in the detection of malignancy, architectural or nuclear features?
    Yucel Polat A; Tepeoglu M; Tunca MZ; Ayva ES; Ozen O
    Cytopathology; 2021 May; 32(3):344-352. PubMed ID: 33606313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of false-negative ThinPrep cervical smears in women with high-grade squamous intraepithelial lesions.
    Leung KM; Lam KK; Tse PY; Yeoh GP; Chan KW
    Hong Kong Med J; 2008 Aug; 14(4):292-5. PubMed ID: 18685162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysplasia, carcinoma in situ, and early invasive cervical carcinoma.
    Nelson JH; Averette HE; Richart RM
    CA Cancer J Clin; 1984; 34(6):306-27. PubMed ID: 6093954
    [No Abstract]   [Full Text] [Related]  

  • 17. ASCUS on cervical cytologic smears. Clinical significance.
    Yang M; Zachariah S
    J Reprod Med; 1997 Jun; 42(6):329-31. PubMed ID: 9219118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colposcopic and histologic findings in women with a cytologic diagnosis of atypical squamous cells of undetermined significance.
    Yarandi F; Izadi Mood N; Mirashrafi F; Eftekhar Z
    Aust N Z J Obstet Gynaecol; 2004 Dec; 44(6):514-6. PubMed ID: 15598287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of cervical intraepithelial neoplasia in women with atypical squamous or glandular cells of undetermined significance cytology: a prospective study.
    Wensveen C; Kagie M; Veldhuizen R; De Groot C; Denny L; Zwinderman K; Trimbos B
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):883-9. PubMed ID: 12911453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.